13450.0Atellica CH Triglycerides_2 (Trig_2)
Albania medical device registration · Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue, Tarrytown, NY, 10591-5097, USA · Invitro · Model Atellica CH Triglycerides_2 (Trig_2) - 11537222 · Registered January 18, 2023
- Risk Class
- Invitro
- Product Model
- Atellica CH Triglycerides_2 (Trig_2) - 11537222
- Product Name
- Atellica CH Triglycerides_2 (Trig_2)
- Registration Date
- January 18, 2023
- Analysis ID
- 13450.0
Një koleksion reagentësh dhe materialesh të tjera shoqëruese të destinuara për t'u përdorur për matjen sasiore të triglicerideve në një kampion klinik, duke përdorur një metodë të spektrofotometrisë enzimë
Access comprehensive regulatory information for Atellica CH Triglycerides_2 (Trig_2) in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue, Tarrytown, NY, 10591-5097, USA. The device was registered on January 18, 2023.
This page provides complete registration details including product model (Atellica CH Triglycerides_2 (Trig_2) - 11537222), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.